Browsing Tag
Param Capital
1 post
OneSource secures $95m from leading investors; Strides Pharma shareholders witness surge in embedded value
OneSource Specialty Pharma Limited, previously known as Stelis Biopharma, has received equity commitments amounting to INR 8,010 million…